psoriasis
Conditions
Interventions
psoriasis:Oral decoction of Qinghe Liangxue Fang
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Adult patients (18-65 years) with plaque psoriasis meeting both Western and traditional Chinese diagnostic criteria; (2) Newly diagnosed treatment-naïve individuals; (3) No systemic treatments administered within the last 4 weeks; (4) Provided signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Individuals experiencing stress-related conditions such as infection pregnancy childbirth or trauma; (2) Those with an allergic disposition or allergies to the components of the formula; (3) Patients with pustular arthropathic or erythrodermic psoriasis or concurrent autoimmune diseases; (4) Patients with severe primary illnesses uncontrolled by standard treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proteomics;transcriptomics;metabolomics; | — |
Secondary
| Measure | Time frame |
|---|---|
| Measure Yourself Medical Outcome Profile;Visual analogue scale;Enzyme-LinkedImmunosorbnent Assay;Self-rating depression scale;Corneometer CM825;reversetranscription-PCR;Psoriasis area and severity index;High-frequency ultrasound of the skin;Hamilton Anxiety Scale;Physician's Global Assessment;Body Surface Area;Dermatology Life Quality Index; | — |
Countries
China
Contacts
Public ContactYanping Bai
China-Japan Friendship Hospital
Outcome results
None listed